Trial
NCT01159054
Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Dialysis
Intervention
Extended Release Nicotinic Acid (Niaspan)
Why stopped
The funding source is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-28